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Abstract - The ethanol extract and methanol fraction of Pityrogramma calomelanos (L.) link were evaluated for antibacte-
rial, antifungal and modulatory activities against strains of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus au-
reus, Candida albicans, C. krusei and C. tropicalis. The antimicrobial activity of the natural products was evaluated by the 
microdilution method associated or not with aminoglycosides and antifungals. The ethanol extract and methanol fraction 
of P. calomelanos showed good activity against S. aureus when associated with aminoglycosides and with benzoilmetron-
idazol against species of the genus Candida. These results indicate that P. calomelanos should be studied as a possible source 
of natural products to combat bacteria and fungi either directly or by modulating the mechanisms of resistance of these 
microorganisms, enhancing the antimicrobial activity of these drugs and combating microbial resistance. 
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INTRODUCTION
Nosocomial  infections  represent  a  serious  prob-
lem to public health, causing a significant increase 
in  morbidity,  mortality  and  hospital  costs  (Boyce, 
2001). Among the major pathogens involved in these 
infections, Staphylococcus aureus is one of the most 
important causal agents (Moraes et al., 2000). The 
clinical manifestations of S. aureus can be cutaneous 
or systemic (Ferreira and Ávila, 2001). The cutaneous 
symptoms include folliculitis, boils, carbuncles and 
the staphylococcal scalded skin syndrome. S. aureus 
is frequently isolated in post-surgical wounds and is 
therefore a serious risk to systemic infections. When 
it causes bacteremia, this can result in endocarditis, 
osteomyelitis, penumonia and meningitis (Koneman 
et al., 2001).
Other  clinically  important  bacteria  are  Es-
cherichia coli and Pseudomonas aeruginosa. E. coli 
has been identified as the primary cause of infections 
of the urinary tract, neonatal meningitis, nosocomial 
septicemia and enteritis. P. aeruginosa is also among 
the  bacteria  with  considerable  clinical  relevance, 
causing infections in immune compromised patients 
as occurs in cystic fibrosis where the secretion sta-
sis make possible the colonization by this bacterium. 
Furthermore, this bacterium presents a high rate of 
mutations that results in progressive resistance to an-
tibiotics and difficulties with anti-infective therapy 
(Oliver et al., 2000).
In this context, a growing and important prob-
lem is the increase of bacterial resistance to antibiot-
ics (Georgopapadakou, 2005). The resistance against 44 T. M. SOUZA   ET AL.
two or more classes of antimicrobials that has been 
a common finding reported in human and veteri-
nary medicine, limits the available therapeutic op-
tions  (Von  Baum  and  Marre,  2005).  For  patients, 
the resistance to antibiotics increases morbidity and 
mortality, which in turn increases the cost to health 
institutions (Dancer, 2001). 
In  folk  medicine,  the  plants  are  used  either 
alone  or  together  with  conventional  medicines 
(Amorim, 1999). In this association, the medici-
nal plants or their sub-products can inhibit or in-
crease the therapeutic effect of conventional drugs 
(Nascimento et al., 2000). The plants with thera-
peutic  properties  used  in  folk  medicine  are  an 
important source of new biologically active com-
pounds. Being complex mixtures, extracts with an-
timicrobial agents present a low possibility for the 
microorganisms  to  acquire  resistance  (Daferera 
et al., 2003). The expression “modifiers of antibi-
otic activity” refers to substances that modulate or 
even reverse bacterial resistance to specific antibi-
otics, as is the case of several natural products of 
plant origin (extracts and phytoconstituents) that 
change the microbial susceptibility to antibiotics 
for inhibition of efflux of pumps (Piddock, 2006; 
Gibbons, 2004).
The family Pteridaceae presents a considerable 
morphological diversity. Most of the species occur in 
the tropics and arid regions. There are 50 genera and 
950 species (Prado, 2005). Pityrogramma is a genus 
with about 17 species occurring mainly in tropical 
America (Smith et al., 2006). The species Pityrogram-
ma calomelanos (L.) Link is used as an ornamental 
and medicinal plant (Ambrósio and Barros, 1997; 
Corrêa, 1984).
Due to the lack of data about the biological ac-
tivity of Brazilian ferns and due to serious problems 
of  resistance  to  antibiotics,  the  objective  of  this 
work is qualitatively identify the chemical compo-
sition of P. calomelanos and to evaluate the antimi-
crobial  and  modulatory  antibiotic  activity  of  the 
ethanol extract and methanol fraction from leaves 
of P. calomelanos.
MATERIALS AND METHODS
Bacterial and fungal strains
The  bacterial  strains  used  were  E.  coli  (EC-
ATCC10536 and EC27), S. aureus (SA-ATCC25923 
and  SA358)  and  P.  aeruginosa  (ATCC15442  e 
PSU03), and the profiles of resistance are given in Ta-
ble 1. The fungal strains used were Candida albicans 
ATCC 40227, C. krusei ATCC 6538 and C. tropicalis 
ATCC 13803. All the strains were kept on heart infu-
sion Agar slants (HIA; Difco) and before the assays, 
the cells were cultured for 24 h at 37°C in brain heart 
infusion (BHI, Difco). All the strains were obtained 
from the collection of microorganisms of the Labo-
ratory of Clinical Mycology - UFPB. 
Plant material
Leaves of P. calomelanos were collected in the city of 
Crato, Ceará, Brazil. The plant material was identified 
by Dr. Antônio Álamo Feitosa Saraiva of the Regional 
University of Cariri, Brazil, and a voucher specimen 
has been deposited with the identification number 
5570 at the Herbarium “Dárdano de Andrade Lima” 
of the Regional University of Cariri – URCA.
Drugs
Solutions with 5 mg/mL of the antibiotics amikacin, 
kanamycin, gentamicin and neomycin were obtained 
from Sigma Co. (St. Louis, USA). Antifungal drugs 
were prepared as follows: solutions of 1024 µg/ml of 
Amphotericin B (Sigma Co., St. Louis, USA), Me-
bendazole (Lasa – Pharmaceutical Industries LTDA., 
Brazil),  Nystatin  (Brazilian  Laboratory  Teuto  S/A, 
Brazil), and Benzoilmetronidazol (Prati, Donaduzzi 
and Cia LTDA., Brazil). The solutions of antibiotic 
and antifungals were prepared according to the rec-
ommendations of NCCLS (2003). 
Preparation of the ethanol extract (EEPC) and  
methanol fraction (MFPC) of P. calomelanos leaves
Leaves (950 g) were dried and kept at room tempera-
ture. The powdered material was extracted by mac-PityRogRAMMA CALoMELANoS 45
Table 1. Origin of bacterial strains and profile of resistance at antibiotics. 
Bacteria Origin Resistance Profile
Escherichia coli 27 Surgical wound Ast,Ax,Ami,Amox,Ca,Cfc,Cf,
Caz,Cip,Clo,Im,Can,Szt,Tet,Tob
Staphaylococcus aureus 358 Surgical wound Oxa,Gen,Tob,Ami,Can,Neo,Para, But,Sis,Net
Pseudomonas Aeruginosa 03 Uroculture Cpm,Ctz,Imi,Cip,Ptz,Lev,Mer,Ami
Ast-Aztreonan; Ax-Amoxacillin; Amp-Ampicillin; Ami-Amicillin; Amox-Amoxillin, Ca-Cefadroxil; Cfc-cefaclor; Cf-Cphalothin; Caz-
Ceftazinidima; Cip-Ciprofloxacin; Clo-Chloraphenicol; Imi-Imipenem; Can-Kanamycin; Szt-Sulphametrim; Tet-Tetracycline; Tob-To-
bramycin; Oxa-Oxacillin; Gen-Gentamicin; Neo-Neomycin;  Para-Paramomicin; But-Butirosin; Sis-Sisomicin; Net-Netilmicin; Com-
Cfepime; Ctz-Ceftazidime;   Ptz-Piperacilin-tazobactam; Lev-Levofloxacin; Mer-Merpenem.
Table 2. Phytochemical screnning of ethanol extract (EEPC) and methanol fraction (FMPC) of Pityrogramma calomelanos (L.) Link.
METABOLITES
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
EE + + + + + + +
MF + + + + + + +
Alkaloids; 2 – Antocianidins; 3 – Antocianins; 4 – Aurones; 5 – Catequines; 6 – Chalcones; 7 - Flavones; 8 – Flavonones; 9 – Flavonols; 
10 – Flavononols; 11 – Phenols; 12 – Leucoantocianidins; 13 – Xanthones 14 – Tannins Pyrogallics; 15 – Saponins; (+) presence; (-) 
ausence; EEPC (ethanol extract of Pityrogramma calomelanos); HFPC (hexane fraction of Pityrogramma calomelanos).
Table 3. Evaluation of antifungal and antibacterial activity of Pityrogramma calomelanos (L.) Link.
Minimum Inhibitory Concentration (MIC) (μg/mL)
Strains EEPC MFPC
C. albicans (ATCC40227) ≥ 1024 ≥ 1024
C. krusei (ATCC6538) ≥ 1024 ≥ 1024
C. tropicalis (ATCC13803 ≥ 1024 ≥ 1024
E. coli (ATCC10536) ≥ 1024 ≥ 1024
S.aureus (ATCC25923) ≥ 1024 ≥ 1024
Pseudomonas aeruginosa (ATCC15442) ≥ 1024 ≥ 1024
Table 4. Evaluation of modulatory antifungal effect of ethanol extract (EE) and methanol fraction (MF) of Pityrogramma calomelanos 
(L.) Link.
C. albicans C.krusei C.tropicalis
ALONE + EE + FM ALONE + EE + FM ALONE + EE + FM
Anphotericin B ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024
Mebendazole ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024
Nystatin ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024 ≥1024
Benzoilmetronidazole ≥1024 ≥1024 128 ≥1024 256 ≥1024 ≥1024 256 ≥1024
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eration using 1 L of ethanol 95% as a solvent at room 
temperature. The mixture was allowed to stand for 72 
h at room temperature. The extract was filtered and 
concentrated under vacuum in a rotary evaporator at 
60ºC and 760 mm/Hg of temperature and pressure, 
respectively (Brasileiro et al., 2006). Aerial parts (950 
g) yielded 50 g of an ethanol extract. Forty g of EEPC 
were fractionated with methanol producing 14.3 g of 
a methanol fraction. The ethanol extract and metha-
nol fraction were diluted using DMSO.
Phytochemical Screening
Phytochemical  assays  are  used  for  the  qualitative 
analysis  of  the  presence  of  secondary  metabolites 
such  as  heterosides,  saponins,  tannins,  flavonoids, 
steroids, triperpens, coumarins, quinones, organics 
acids and alkaloids, and were performed according 
to the method described by Matos (2009). The tests 
are based on the observation of color modification 
and precipitate formation after the addition of specif-
ic reagents. Table 2 presents the metabolites observed 
in the ethanol extract and methanol fraction.
Minimum inhibitory Concentration (MiC)
The Minimum Inhibitory Concentration (MIC) was 
determined in BHI 10% by the method of microdi-
lution, using a suspension of 105 UFC/mL and an 
initial drug concentration of 1024 μg/mL for fungi 
and 5000 μg/mL for bacteria (Javadpour et al., 1996). 
The MIC was defined as the lowest concentration at 
which no growth was observed. To evaluate the etha-
nol extract and methanol fraction as modulators of 
resistance to antibiotics and antifungal agents, the 
sub-inhibitory concentration was used with the an-
tibiotic solution (MIC/8 = 128 μg/mL). The plates 
were incubated for 24 h at 37°C. To visualize bacte-
rial growth, resazurine was used. No dye was used in 
the fungal assay. 
RESULTS AND DISCUSSION
Neither EE nor MF demonstrated an antimicrobial 
activity clinically relevant to fungi or bacteria. The 
values of MIC are presented in Table 3. However, in 
the modulation assay it was verified that the etha-
nol  extract  and  methanol  fraction  modulated  the 
most of the antibiotics tested against S. aureus, with 
the exception to amikacin associated with MF and 
neomycin  with  EE,  indicating  relevant  properties 
of the fraction and extract to enhance the action of 
aminoglycosides against S. aureus. Against E. coli, 
the ethanol extract promoted modulation of the ac-
tion of amikacin and kanamycin. Against P. aerugi-
nosa no modulatory activity was observed. In the 
modulation  of  antifungal  activity,  it  was  observed 
that MF modulated the antifungal action of benzoil-
metronidazol against C. albicans. Against C. krusei 
and C. tropicalis, the EE promoted modulation in the 
effect of benzoilmetronidazol. These results are the 
first reports about the antimicrobial or modulatory 
activities of P. calomelanos (Tables 4 and 5).
The mechanisms through which the extracts could 
inhibit the growth of microorganisms are several and 
can due at hydrophobic nature of some components. 
These components can interact with the lipid layer 
Table 5. Evaluation of modulatory antibacterial effect of ethanol extract (EE) and methanol fraction (MF) of Pityrogramma calomelanos 
(L.) Link.
E. coli 27 S. aureus 358 Paeruginosa 03
Alone + EE + FM Alone + EE + FM Alone + EE + FM
Amikacin  ≥5000 312,5 1250 78,125 9,765 78,125 1250 1250 1250
Kanamycin 2500 625 2500 156,25 39,06 39,06 2500 2500 2500
Gentamicin  625 625 625 312,5 4,88 4,88 1250 2500 2500
Neomycin   156,25 156,25 156,25 156,25 156,25 39,06 625 625 625
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of the cell membrane, affecting the respiratory chain 
and energy production, or even making the cell more 
permeable to antibiotics, thus disrupting vital cellu-
lar processes (Nicolson et al., 1999; Burt, 2004). Vari-
ous components of the extracts or fractions increase 
the permeability of the cell, increasing the entry of 
antibiotics (Helander et al., 1998). This mechanism 
can be obtained by the combination of antibiotics 
with extracts or fractions at sub-inhibitory concen-
trations when applied directly to the culture medium 
(Coutinho et al., 2010a). No modulatory activity was 
found to be associated with the fern. However, sev-
eral natural products from plants and animals have 
been studied (Ferreira et al., 2009; Coutinho et al., 
2010b; Rodrigues et al., 2009).
This strategy is called “herbal shotgun” or “syn-
ergistic multi-effect targeting” and refers to the uti-
lization of plants and drugs in an approach using 
mono- or multi-extract combinations, which can 
affect not only a single target but also various tar-
gets,  where  the  different  therapeutic  components 
collaborate in a synergistic-agonistic manner. This 
approach  is  not  only  meant  for  combinations  of 
extracts. Combinations of natural products or ex-
tracts and synthetic products or antibiotics are also 
possible (Coutinho et al., 2008; Wagner and Ulrich-
Merzenich, 2009).
The results obtained in this study are promising 
and are an incentive for future research into the phar-
macological aspects and toxicity of sub-products of 
P. calomelanos with the objective of promoting their 
possible rational use in antifungal and antibacterial 
therapy, as well as for resolving some of the questions 
of resistance to antibiotics.
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